SAT0657 CAN VASCULAR INFLAMMATION IN RA BE DETECTED USING CONTRAST ENHANCED MRI? PRELIMINARY RESULTS

S
Background: In rheumatoid arthritis (RA) vascular inflammation may contribute to excess cardiovascular (CV) risk. Contrast enhanced MRI has been used to detect vascular inflammation in Takayasu's arteritis. In RA, its utility has not been studied but it may provide a method of identifying and monitoring vascular inflammation and effects of therapy. Objectives: We sought to compare carotid artery wall enhancement on contrast enhanced MRI in RA patients and controls and evaluate association with circulating markers of inflammation, endothelial activation and CV risk factors. Methods: Patients and age/sex matched controls underwent clinical and serological assessment (details in Table 1 ) and a screening carotid ultrasound. Those with wall thickening>2mm had a carotid MRI. T 1 -weighted images were acquired before and after gadopentate injection on a 3T scanner. Increase in mean signal intensity (SI) in the carotid vessel wall normalised to adjacent skeletal muscle provided a global enhancement metric (WE G ). Histograms of distribution of SIs on pre-and post-contrast images were generated and bimodal Gaussian distributions fitted to explore patterns of enhancement within the wall. MRI measurements were compared between groups and association with serological markers tested using non-parametric statistics.
Results: 27 patients and 10 controls underwent MR imaging. Key characteristics are seen in Table 1 . There was no difference in WE G between groups and no association with serological markers. However a bimodal distribution of SI in vessel wall was observed (Figure 1 ) and in exploratory analysis these two components were analysed separately. For the low-signal component enhancement (WE low ) correlated with ESR, I-CAM, e-selectin (r=0.39,p=0.03;r=0.44,p=0.01;r=0.37,p=0.04). There was a trend towards correlation with CRP (r=0.30,0.08) and towards higher values in patients (median 0.20 (0.15, 0.33) vs 0.14 (0.11, 0.22),p=0.051). Enhancement in the high-signal component (WE high ) was not associated with serological markers or RA status. Background: Carpal tunnel syndrome (CTS) is the most frequent neuropathy of all entrapment neuropathies in the general population. Rheumatoid arthritis (RA) is one of the disease generate secondary CTS. The pathophysiology of CTS of RA might be different from idiopathic CTS. RA is a disease that has the characteristics to generate inflammatory synovial proliferation of the joint and also tendon. Although inflammation of the wrist joint and synovial tissue of the flexor tendons can cause increased pressure in the carpal tunnel, there is a possibility that even RA patients without symptoms of CTS also have subclinical median nerve damage because of the synovial proliferation and inflammation. Objectives: The aim of this study was to assess and compare the stiffness of the median nerve measured by quantitative elastosonography between patients with RA without symptom of CTS and controls. Methods: Four hundred two hands in 201 patients with RA and 222 hands in controls were included. All participants were examined both wrists. Ultrasound (US) examination was performed by using a 5-to 18-MHz linear array transducer (HI VISION Ascendus; HitachiAloka Medical,Tokyo, Japan). As a reference medium, an acoustic coupler (EZUTECPL1; HitachiAloka Medical) with a standardized
